Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 324 of 1,261
  1. US 11083635

    Tampon delivery system for a pharmaceutical, holistic or medicinal component

    Herphoric, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  2. US 11083696

    Dispersion anaesthetic device

    University College Cardiff Consultants Limited · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  3. WO 2021152186

    ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES

    BAYER AG [DE] · Granted Aug 5, 2021 · Expires Jul 31, 2041

    granted
  4. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  5. US 11078491

    Vaccines against Zika virus based on Zika structure proteins

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 11078295

    Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases

    VACCINEX, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  7. US 11078286

    Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  8. US 11078266

    Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  9. US 11077077

    Therapeutic compounds, formulations, and uses thereof

    Tvardi Therapeutics, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  10. US 11077109

    Compounds having antibacterial activity and methods of use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  11. US 11078252

    T-cell receptor

    University College Cardiff Consultants Limited · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  12. US 11078201

    Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists

    Nimbus Saturn, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  13. US 11078205

    Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  14. US 11078245

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  15. US 11078190

    Polymorphs of selinexor

    Karyopharm Therapeutics Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  16. US 11077241

    Standardizations and medical devices for the preparation of platelet rich plasma (PRP) or bone marrow concentrate (BMC) alone or in combination with hyaluronic acid

    RegenLab USA LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  17. US 11077182

    Methods of preparing anti-human papillomavirus antigen T cells

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  18. US 11078168

    Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

    Phenex Discovery Verwaltungs-GmbH · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  19. US 11077200

    Combined enteropathogen recombinant construct

    United States of America as represented by the Secretary of the Air Force · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  20. US 11077197

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  21. US 11077175

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  22. US 11077123

    Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  23. US 11077114

    Stabilized formulations of CNS compounds

    Supernus Pharmaceuticals, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  24. US 11077117

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.